• Policy
• Janssen Korea voluntarily withdrew Tylenol 500mg
• by Lee, Tak-Sun Dec 10, 2021 05:51am

• Policy
• The method of writing for HBP combination is improved
• by Lee, Tak-Sun Dec 10, 2021 05:51am

• Policy
• The ruling party shouted to review the Judiciary Committee
• by Lee, Jeong-Hwan Dec 9, 2021 05:58am

• Policy
• 6 cases of Ultomiris & 1 case of Spinraza were pre-approved
• by Lee, Hye-Kyung Dec 9, 2021 05:58am

• Policy
• Patients fume over non-deliberation of Kymriah·Keytruda
• by Lee, Jeong-Hwan Dec 9, 2021 05:58am

• Policy
• Impurity detected Cozaar is excluded from recovery
• by Lee, Tak-Sun Dec 8, 2021 06:01am

• Policy
• No recall crisis expected to arise from losartan impurities
• by Lee, Tak-Sun Dec 8, 2021 06:00am

• Policy
• Detailed screening for α -GPC begins in earnest next year
• by Moon, sung-ho Dec 7, 2021 05:57am

• Policy
• The original patent's negotiation period will be reduced
• by Kim, Jung-Ju Dec 7, 2021 05:57am

• Policy
• KB Pharm's generic for Vildagliptin nitrate will be approved
• by Lee, Tak-Sun Dec 6, 2021 05:54am